Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Recruiting · NCT05046613 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Not stated | 2026-05-05 | NCT05046613 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
| PPD, Part of Thermo Fisher Scientific | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Evidera, a PPD business unit | Wilmington | United States | 1 |